Raily Aesthetic Medicine International Holdings Limited (HK:2135) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Raily Aesthetic Medicine International Holdings Limited reported its interim financial results, showing a reduced loss for the first half of 2024 compared to the same period in 2023. Revenue increased from 97.58 million to 117.475 million RMB, while the company’s loss per share decreased from 0.47 cent to 0.32 cent, indicating a modest improvement in financial performance.
For further insights into HK:2135 stock, check out TipRanks’ Stock Analysis page.